Search results
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade via AOL· 3 days agoHow Can You Protect Yourself From COVID-19-Related Cardiovascular Issues? Get your COVID-19 ...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 5 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 4 days agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
Tests to begin for COVID treatment developed in South Carolina
News 12 Augusta· 1 day agoState lawmakers approved millions of dollars for research on a new COVID-19 treatment that will soon...
Anthony Fauci addresses COVID-19 controversies on Capitol Hill
Market Watch· 4 days agoTop infectious-disease expert Anthony Fauci addressed some of the COVID-19 pandemic’s most heated...
New COVID subvariants are rising: How bad will California get hit this summer?
LA Times via Yahoo News· 7 days agoLast summer's COVID wave in California was big enough to cause significant disruptions. As a new...
Bird Flu Is Spreading. Here’s Everything You Should Know Right Now
Self via Yahoo News· 11 hours ago“From a day-to-day life standpoint, there's not any risk right now. But there wasn't any risk to...
China envoys deliver Xi's invite to African leaders for September FOCAC summit
South China Morning Post via Yahoo Finance· 17 hours agoChinese diplomats are delivering invitation letters to leaders across Africa for the next key...
Scientists are testing vaccines to protect cows and people against bird flu
Temple Daily Telegram· 4 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...